Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27533 | 227 | 34.3 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
415 | 2 | CYTOCHROME P450//CYP2D6//PREGNANE X RECEPTOR | 16559 |
27533 | 1 | PHARMACOKINET BIOANAL//HUMANIZED LIVER//PL DEV BIOL | 227 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PHARMACOKINET BIOANAL | address | 3549136 | 22% | 54% | 49 |
2 | HUMANIZED LIVER | authKW | 823915 | 3% | 88% | 7 |
3 | PL DEV BIOL | address | 586968 | 5% | 36% | 12 |
4 | P450 SUBSTRATES | authKW | 560486 | 2% | 83% | 5 |
5 | KEIO ADV | address | 369905 | 5% | 25% | 11 |
6 | TK NOG MOUSE | authKW | 302662 | 1% | 75% | 3 |
7 | UPA SCID MOUSE | authKW | 302662 | 1% | 75% | 3 |
8 | 21ST CENTURY COE PROGRAM ADV RADIAT CASUALTY MED | address | 284852 | 3% | 35% | 6 |
9 | COOPERAT LINK UNIQUE SCI TECHNOL ECON REVITALIZ | address | 280238 | 2% | 42% | 5 |
10 | CYNOMOLGUS MONKEY | authKW | 269819 | 14% | 6% | 31 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2720 | 63% | 0% | 143 |
2 | Toxicology | 1860 | 27% | 0% | 62 |
3 | Medicine, Legal | 88 | 2% | 0% | 5 |
4 | Transplantation | 27 | 3% | 0% | 6 |
5 | Gastroenterology & Hepatology | 25 | 4% | 0% | 9 |
6 | Chemistry, Medicinal | 20 | 4% | 0% | 8 |
7 | Multidisciplinary Sciences | 18 | 2% | 0% | 4 |
8 | Biochemistry & Molecular Biology | 17 | 12% | 0% | 27 |
9 | Biophysics | 14 | 4% | 0% | 9 |
10 | Medicine, Research & Experimental | 12 | 4% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOKINET BIOANAL | 3549136 | 22% | 54% | 49 |
2 | PL DEV BIOL | 586968 | 5% | 36% | 12 |
3 | KEIO ADV | 369905 | 5% | 25% | 11 |
4 | 21ST CENTURY COE PROGRAM ADV RADIAT CASUALTY MED | 284852 | 3% | 35% | 6 |
5 | COOPERAT LINK UNIQUE SCI TECHNOL ECON REVITALIZ | 280238 | 2% | 42% | 5 |
6 | YOSHIZATO PROJECT | 253196 | 4% | 24% | 8 |
7 | LIVER PROJECT | 229608 | 6% | 13% | 13 |
8 | PXB MOUSE PROD | 179355 | 1% | 67% | 2 |
9 | DRUG METAB PHARMACOKINET | 149102 | 25% | 2% | 57 |
10 | 21ST CENTURY COE PROGRAM ADV RADIAT CASULATY MED | 134517 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND PHARMACOKINETICS | 53886 | 7% | 2% | 17 |
2 | XENOBIOTICA | 40218 | 15% | 1% | 34 |
3 | DRUG METABOLISM AND DISPOSITION | 21990 | 15% | 0% | 35 |
4 | BIOPHARMACEUTICS & DRUG DISPOSITION | 2506 | 3% | 0% | 6 |
5 | HUMAN GENE THERAPY CLINICAL DEVELOPMENT | 1659 | 0% | 1% | 1 |
6 | DRUG METABOLISM REVIEWS | 1212 | 1% | 0% | 3 |
7 | REGULATORY TOXICOLOGY AND PHARMACOLOGY | 1148 | 2% | 0% | 5 |
8 | CURRENT DRUG METABOLISM | 1101 | 1% | 0% | 3 |
9 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 966 | 1% | 0% | 3 |
10 | CHEMICAL RESEARCH IN TOXICOLOGY | 923 | 3% | 0% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HUMANIZED LIVER | 823915 | 3% | 88% | 7 | Search HUMANIZED+LIVER | Search HUMANIZED+LIVER |
2 | P450 SUBSTRATES | 560486 | 2% | 83% | 5 | Search P450+SUBSTRATES | Search P450+SUBSTRATES |
3 | TK NOG MOUSE | 302662 | 1% | 75% | 3 | Search TK+NOG+MOUSE | Search TK+NOG+MOUSE |
4 | UPA SCID MOUSE | 302662 | 1% | 75% | 3 | Search UPA+SCID+MOUSE | Search UPA+SCID+MOUSE |
5 | CYNOMOLGUS MONKEY | 269819 | 14% | 6% | 31 | Search CYNOMOLGUS+MONKEY | Search CYNOMOLGUS+MONKEY |
6 | CYP2C76 | 269034 | 1% | 100% | 2 | Search CYP2C76 | Search CYP2C76 |
7 | CYP2D17 | 269034 | 1% | 100% | 2 | Search CYP2D17 | Search CYP2D17 |
8 | FRG MOUSE | 269034 | 1% | 100% | 2 | Search FRG+MOUSE | Search FRG+MOUSE |
9 | HUMAN CHIMERIC MICE | 269034 | 1% | 100% | 2 | Search HUMAN+CHIMERIC+MICE | Search HUMAN+CHIMERIC+MICE |
10 | LIVER HUMANIZATION | 269034 | 1% | 100% | 2 | Search LIVER+HUMANIZATION | Search LIVER+HUMANIZATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KITAMURA, S , SUGIHARA, K , (2014) CURRENT STATUS OF PREDICTION OF DRUG DISPOSITION AND TOXICITY IN HUMANS USING CHIMERIC MICE WITH HUMANIZED LIVER.XENOBIOTICA. VOL. 44. ISSUE 2. P. 123 -134 | 43 | 67% | 9 |
2 | ITO, S , KAMIMURA, H , (2016) ASSESSMENT OF CHIMERIC MICE WITH HUMANIZED LIVERS IN NEW DRUG DEVELOPMENT: GENERATION OF PHARMACOKINETICS, METABOLISM AND TOXICITY DATA FOR SELECTING THE FINAL CANDIDATE COMPOUND.XENOBIOTICA. VOL. 46. ISSUE 6. P. 557 -569 | 39 | 59% | 0 |
3 | UNO, Y , UEHARA, S , YAMAZAKI, H , (2016) UTILITY OF NON-HUMAN PRIMATES IN DRUG DEVELOPMENT: COMPARISON OF NON-HUMAN PRIMATE AND HUMAN DRUG-METABOLIZING CYTOCHROME P450 ENZYMES.BIOCHEMICAL PHARMACOLOGY. VOL. 121. ISSUE . P. 1 -7 | 36 | 58% | 1 |
4 | FOSTER, JR , LUND, G , SAPELNIKOVA, S , TYRRELL, DL , KNETEMAN, NM , (2014) CHIMERIC RODENTS WITH HUMANIZED LIVER: BRIDGING THE PRECLINICAL/CLINICAL TRIAL GAP IN ADME/TOXICITY STUDIES.XENOBIOTICA. VOL. 44. ISSUE 2. P. 109-122 | 41 | 35% | 10 |
5 | UEHARA, S , MURAYAMA, N , NAKANISHI, Y , ZELDIN, DC , YAMAZAKI, H , UNO, Y , (2011) IMMUNOCHEMICAL DETECTION OF CYTOCHROME P450 ENZYMES IN LIVER MICROSOMES OF 27 CYNOMOLGUS MONKEYS.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. VOL. 339. ISSUE 2. P. 654-661 | 26 | 59% | 5 |
6 | SCHEER, N , WILSON, ID , (2016) A COMPARISON BETWEEN GENETICALLY HUMANIZED AND CHIMERIC LIVER HUMANIZED MOUSE MODELS FOR STUDIES IN DRUG METABOLISM AND TOXICITY.DRUG DISCOVERY TODAY. VOL. 21. ISSUE 2. P. 250 -263 | 38 | 27% | 4 |
7 | UNO, Y , MATSUNO, K , MURAYAMA, N , NAKAMURA, C , YAMAZAKI, H , (2011) METABOLISM OF P450 PROBE SUBSTRATES BY CYNOMOLGUS MONKEY CYP2C76.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. VOL. 109. ISSUE 4. P. 315 -318 | 16 | 89% | 1 |
8 | SANOH, S , OHTA, S , (2014) CHIMERIC MICE TRANSPLANTED WITH HUMAN HEPATOCYTES AS A MODEL FOR PREDICTION OF HUMAN DRUG METABOLISM AND PHARMACOKINETICS.BIOPHARMACEUTICS & DRUG DISPOSITION. VOL. 35. ISSUE 2. P. 71-86 | 31 | 40% | 5 |
9 | IWASAKI, K , KITSUGI, Y , IKEDA, K , YOSHIKAWA, T , HOSAKA, S , UEHARA, S , UNO, Y , UTOH, M , YAMAZAKI, H , (2016) IN VIVO INDIVIDUAL VARIATIONS IN PHARMACOKINETICS OF EFAVIRENZ IN CYNOMOLGUS MONKEYS GENOTYPED FOR CYTOCHROME P450 2C9.BIOPHARMACEUTICS & DRUG DISPOSITION. VOL. 37. ISSUE 6. P. 379 -383 | 13 | 87% | 0 |
10 | UEHARA, S , UNO, Y , INOUE, T , KAWANO, M , SHIMIZU, M , TODA, A , UTOH, M , SASAKI, E , YAMAZAKI, H , (2016) INDIVIDUAL DIFFERENCES IN METABOLIC CLEARANCE OF S-WARFARIN EFFICIENTLY MEDIATED BY POLYMORPHIC MARMOSET CYTOCHROME P450 2C19 IN LIVERS.DRUG METABOLISM AND DISPOSITION. VOL. 44. ISSUE 7. P. 911 -915 | 15 | 71% | 0 |
Classes with closest relation at Level 1 |